INTRODUCTION {#sec1-1}
============

Sexually transmitted infections (STI) are a group of infectious diseases where the epidemiologically important mode of transmission occurs during sexual intercourse or intimate genital contact.\[[@ref1]\] There are severe complications implicated with untreated STIs, and they are also known to amplify the risk of HIV transmission.\[[@ref2]\] Also, human papillomavirus (HPV) which causes genital warts, is implicated in cancer of the cervix in women.\[[@ref3]\]

According to the WHO global summit (2012),\[[@ref4]\] there are 340 million new cases of syphilis, gonorrhea, chlamydiasis and trichomoniasis in the 15--49 age group. HPV infections constitute 5,00,000 cases/year of which 80% are reportedly from developing countries.\[[@ref4][@ref5]\] A large proportion of STIs are asymptomatic or sub-clinical and hence go undiagnosed. But, the good news is that many STIs are preventable with appropriate screening, especially in high-risk individuals.

The diagnostic tests for STIs help diagnose typical cases, and also atypical, asymptomatic and multiple infections. Their nondiagnostic uses include-screening high-risk groups, monitoring treatment, surveillance, outbreak investigations, validation of syndromic management, detection of antimicrobial resistance patterns (e.g., in *Neisseria gonorrhea*), ensuring quality assurance in laboratory tests and research purposes.\[[@ref6]\]

The laboratory diagnosis of STIs include:

Direct microscopy to demonstrate the organismCulture/isolation of organismsAntigen detectionSerology for detection of antibodiesTests that detect microbial metabolites (e.g., Whiff test)Molecular methods of diagnosis.

The merits and demerits of existing diagnostic tests for various STIs have been highlighted in [Table 1](#T1){ref-type="table"}.\[[@ref7][@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18]\] From the table, it is evident that many of the routinely performed tests lack sensitivity, specificity and speed. The molecular diagnostic methods promise to deliver on all these counts.

###### 

Challenges in routine diagnostic tests for STIs
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OVERVIEW OF MOLECULAR METHODS FOR DIAGNOSIS OF SEXUALLY TRANSMITTED INFECTIONS {#sec1-2}
==============================================================================

The molecular methods are useful for microorganisms that are difficult to culture. They have a fairly recent history of just over 40 years. They are increasingly being accepted by clinicians as viable options in their practice. In 1961 Marmur and Doty described the nucleic acid hybridization (NAH) technique. It gained immense popularity, especially DNA probes, although limited by its sensitivity. All this changed in 1983, when Kary Mullis conceived and developed the polymerase chain reaction (PCR).\[[@ref19]\]

What are NATs? Nucleic acid tests are techniques that detect specific sequences in DNA or RNA of a microorganism that may be associated with disease. There are 3 broad types of assays used in molecular diagnostics:\[[@ref20]\]

Hybridization techniques -- e.g., NAHAmplification techniques -- e.g., PCRAssays used in Epidemiological investigations -- e.g., strain typing and identification.

Uses of molecular techniques in management of sexually transmitted infections {#sec2-1}
-----------------------------------------------------------------------------

Detection of microorganisms that are difficult/impossible to culture.\[[@ref19][@ref21]\] E.g., HPV, *Treponema pallidum*Identification of organisms isolated in pure cultureRapid identification of organisms, from clinical specimensDifferentiation between closely related organisms (e.g., herpes simplex virus \[HSV\]-1 and 2)Understanding the epidemiology and pathophysiology of STIs (e.g., DNA fingerprint analysis)Improving sensitivity and specificity of serological assays by using cloned proteins and recombinant antigens.

TYPES OF MOLECULAR METHODS {#sec1-3}
==========================

Nucleic acid hybridization techniques {#sec2-2}
-------------------------------------

These assays rely on sensitivity and specificity of hybridization reactions (binding) between probe and target nucleic acid (NA). The DNA/RNA of the microorganism in the clinical specimen is called the target NA, while the complementary, single stranded DNA/RNA oligonucleotide NA attached to a reporter chemical/radionucleotide/fluorescent dye, is called the probe NA.

Amplification techniques {#sec2-3}
------------------------

There is an exponential increase in target NA copies, such that their numbers are high enough to be identified by various detection methods. The amplification may be of Target, Probe or Signal.

Strain typing and identification {#sec2-4}
--------------------------------

These assays determine strain relatedness between NAs from various sources for epidemiological investigations.

Basic steps in molecular diagnosis involve {#sec2-5}
------------------------------------------

Specimen collectionSpecimen processing-extraction and purification of NA from clinical samplesAmplification or hybridization - depending on the test method usedDetection of end products of amplification or hybridization, by appropriate methods.

Nucleic acid hybridization {#sec2-6}
--------------------------

Two single NA strands with complementary base sequences specifically bond with each other forming a double-stranded molecule (duplex or hybrid). The single stranded molecules may be DNA or RNA. Thus, hybrids may be DNA-DNA, DNA-RNA or RNA-RNA. The target (template) may be *in situ*, free in solution or immobilized on a solid support.

Hybrid capture technology {#sec2-7}
-------------------------

This is an example of *in vitro* NAH assay using a microtitre plate and chemiluminiscence for the qualitative detection of NA targets in specimens (sensitivity - 85% and specificity-nearly 100%).

Applications of nucleic acid hybridization technology {#sec2-8}
-----------------------------------------------------

Direct detection of microorganisms from specimens, using chemiluminiscence labeled probes.\[[@ref21][@ref22]\] E.g., HBV, HSV, PACE-2 (GenProbe). Also used for confirmation of microorganisms isolated in pure cultures.

Amplification techniques {#sec2-9}
------------------------

There are three types of amplification methods:

### Target amplification {#sec3-1}

Here the target NA in the sample is amplified and then detected by various methods. It is very popular and includes PCR, real-time PCR and reverse transcription-PCR.

### Signal amplification {#sec3-2}

Here the signal is amplified after hybridizing a probe to an organism\'s NA (target). Cross-contamination is less common in this. E.g., branched chain DNA detection. These assays are available for quantification of RNA from HCV and HIV, and DNA from HBV.

### Probe amplification {#sec3-3}

An example of this technique is ligase chain reaction in which DNA ligase enzyme is used to seal the gap between two probes annealed to the target DNA. The sealed probe is then used as a target for amplification in subsequent steps. Once used to identify *Chlamydia trachomatis* (CT) and *N. gonorrhea(NG)* from clinical specimens, the test has now lost its popularity.

The following section will describe the most popular amplification method used in molecular diagnosis of STIs:

### Polymerase chain reaction {#sec3-4}

This technique is akin to a "Xerox machine" in which millions of identical copies of the target NA are generated.

### Steps in polymerase chain reaction {#sec3-5}

NA (DNA) extraction from specimenDenaturation of DNA strandsAnnealing (attachment) of oligonucleotide primers to single stranded DNA strandsPrimer extension to form complementary strands (amplification)Detection of products of amplification (amplicons).

Advantages of polymerase chain reaction {#sec2-10}
---------------------------------------

Rapid detection timeIncreased sensitivity and specificitySome provide quantitative data (e.g., viral load in real-time PCR)Automated NA isolation systems possible.

Disadvantages of polymerase chain reaction {#sec2-11}
------------------------------------------

Cost, instrumentation, requirement of trained manpower and space, false positive (contamination), nonspecific amplification or no amplification.

Types of polymerase chain reaction {#sec2-12}
----------------------------------

### Conventional polymerase chain reaction {#sec3-6}

As described above.

### Real-time polymerase chain reaction {#sec3-7}

This is an innovative breakthrough for the detection of PCR products. Here the target amplicons are detected in real-time (30-40 min) as they accumulate after each cycle once a threshold is reached. Thus, the detection is exponential, rather than an end-point analysis, and uses the fluorescence-based technology. Also, it is a closed system with no accumulation of hazardous waste, no contamination, no postamplification processing and the imaging system is a part of the real-time instrumentation. It is cost-effective, with a high throughput and sensitivity and specificity. Quantitation is also possible, such as viral load estimation in HIV infection.

### Reverse transcription polymerase chain reaction {#sec3-8}

This is a very sensitive technique for detecting and quantifying mRNA, especially useful to detect RNA viruses from clinical specimens. This method uses the enzyme Reverse Transcriptase to synthesize a complementary strand of DNA (cDNA) from an RNA template. The resulting cDNA serves as a target and is amplified just as described in conventional PCR.

### Multiplex polymerase chain reaction {#sec3-9}

Here, it is possible to simultaneously detect two or more different targets in one PCR tube. Inclusion of internal controls is important to make the assay results dependable. E.g., both CT and NG in a single PCR tube. There is also a multiplex PCR available for the detection of organisms causing genital ulcer disease (*T. pallidum, Haemophilus ducreyi* and HSV 1 and 2).

### Nested polymerase chain reaction {#sec3-10}

A very sensitive and specific PCR technique involving two different, consecutive PCRs. The amplicons derived from the first PCR reaction, serve as the targets for the second PCR. The second primer pair is complementary to an internal region of amplicons derived from first PCR. This increases its specificity.

### Broad-range {#sec3-11}

Polymerase chain reaction-used to identify broad taxonomic groups of organisms.

Transcription mediated amplification {#sec2-13}
------------------------------------

This is an isothermic amplification procedure at 41°C, that does not require a thermal cycler. Transcription mediated amplification (TMA) targets rRNA sequences of microorganisms, producing 100--1000 transcripts in each cycle, using two enzymes. The RNA transcripts are detected by hybridization probe assay. The commercial APTIMA system automates the TMA method for laboratories with high volume.\[[@ref23]\]

Nucleic acid sequence based amplification {#sec2-14}
-----------------------------------------

Another isothermic technique very similar to TMA, used mostly for RNA viruses. It is a self-sustained sequence replication, where three enzymes are used, and the amplification process results in formation of RNA amplicons. NA sequence based amplification (NASBA) is useful in detecting many RNA viruses such as HIV-1.

Strain typing and identification (DNA/genetic fingerprinting)\[[@ref19]\] {#sec2-15}
-------------------------------------------------------------------------

These typing methods determine the genetic relatedness in microorganisms. They are based on the mutations that accumulate over time in many organisms. These methods are broadly divided into nonamplified and amplified methods. For a detailed description of these methods, the reader is advised to refer to appropriate literature.

DNA microarray (gene chip/DNA chip) {#sec2-16}
-----------------------------------

This is a novel and exciting method of evaluating the gene expression from an entire organism, or even from several organisms, as per requirement. It consists of a microscopic grouping of DNA molecules attached to a solid support mechanism, in the form of spots, called reporters. Fluorescently labeled DNA/RNA strands from specimens are incubated with these chips and a scanner reads the fluorescence of hybrids only. A DNA microarray has the potential to detect nearly all pathogens simultaneously.\[[@ref24]\]

Proteomics {#sec2-17}
----------

This is also a molecular level diagnostic technology, but here, unlike NAs like DNA or RNA, proteins at the cellular level are studied. The proteome of an organism is the sum of proteins found during all changing conditions of the cell. Proteomics is used to determine protein expression in disease conditions, including infectious diseases.

Common fallacies in molecular assays {#sec2-18}
------------------------------------

False positive reactions may occur due to carry-over contamination (amplicons) from previously amplified products.\[[@ref21][@ref25]\] There may be exogenous target DNA in reagents, water, kits, sterile blood culture material etc., Poor primer design may also lead to nonspecific reactions.

False negative reactions-may occur due to inadvertent loss of template NA target due to poor extraction, handling and storage protocols, poor primer design (nonconserved regions at primer sites).

APPLICATIONS OF MOLECULAR DIAGNOSTIC METHODS FOR SEXUALLY TRANSMITTED INFECTIONS {#sec1-4}
================================================================================

Gonorrhea {#sec2-19}
---------

Usually tested along with CT.\[[@ref26]\] Available tests include - NAH, nucleic acid amplification test (NAAT) and multiplex PCR. Results are available in \<24 h. Specimens include endocervical or even vaginal swabs in females. Urethral, rectal and oropharyngeal swabs can also be used. In heterosexual males urethral swab or urine specimens can be used for NAAT. In men having sex with men MSM, in addition to the above, rectal and oropharyngeal swabs may be used.

The sensitivity of NAAT (95%), is superior to culture, especially for rectal and pharyngeal swabs, but specificity is less. Only NAAT for urethral swab is presently Food and Drug Administration (FDA), USA approved. And culture is the only method for antimicrobial susceptibility.

HIV {#sec2-20}
---

Qualitative testing for proviral DNA or RNA can be done by PCR for diagnosis. Detection of HIV RNA, DNA or p24 is important for early infant diagnosis and also for detection of HIV infection during the "window period."

For management and monitoring of treatment, quantitative testing is desirable, such as viral load estimation, which can be accomplished by real-time PCR, TMA, NASBA or signal amplification methods. And for drug resistance testing, genotyping is the method of choice.

Chlamydiasis {#sec2-21}
------------

Nucleic acid hybridization is useful and sensitive for CT, with results in \<24 h. E.g., GenProbe PACE-2 and PACE2C (Probe assay chemiluminiscence enahanced). But these are less sensitive than NAAT methods. NAAT is highly successful for Chlamydia because it reduces the need for strict transport and storage of specimens. Also, it can be combined with *N. gonorrhea*, and is highly sensitive and specific, with freedom to use a wide variety of specimen types. It also removes the bias of subjective analysis.\[[@ref27]\]

Herpes simplex virus 1 and 2 {#sec2-22}
----------------------------

Nucleic acid amplification tests are now the gold standard for HSV 1 and 2. Real-time PCR is ideal for skin lesions and allows detection of asymptomatic HSV shedding. The primers may be common to HSV-1 and 2 or only one, and results are available in 24--48 h. Sensitivity and specificity touch 98% and 100%, respectively.\[[@ref28]\] The method is good for cerebrospinal fluid samples too, although not validated for all types of samples. However, it is important to remember that a negative PCR result does not mean absence of infection.

Mycoplasma genitalium infection {#sec2-23}
-------------------------------

Nucleic acid amplification test for Mycoplasma can be performed on first void urine samples in males and vaginal swab in females. TMA can be used with 16s rRNA as the targets. Presently this is only used for research purposes.

Human papillomavirus {#sec2-24}
--------------------

Earlier, the Pap test was the gold standard to diagnose these infections, but now, PCR is recommended by FDA, USA, as first line test.

Chancroid {#sec2-25}
---------

DNA probes and PCR are useful options for *H. ducreyi*, since diagnosis by culture and smear have very poor sensitivity.

Lympho granuloma venereum {#sec2-26}
-------------------------

Polymerase chain reaction is available. The pmpH gene deletion is seen only in lympho granuloma venereum isolates, which may prove useful in its diagnosis.

Trichomoniasis {#sec2-27}
--------------

Several molecular methods are available for its diagnosis. These can be useful if properly standardized.\[[@ref29]\]

Bacterial vaginosis {#sec2-28}
-------------------

Although NAAT methods are available, the diagnosis of BV by molecular methods is not really indicated. Affirm VP-III -- uses DNA hybridization to detect *Gardnerella vaginalis*.\[[@ref30]\]

Other sexually transmitted infections {#sec2-29}
-------------------------------------

The genital ulcer multiplex PCR (test), uses primers for Syphilis, HSV, Chancroid and Donovanosis, in a single test procedure. Currently, this is not available in most countries.

Point-of-care tests {#sec2-30}
-------------------

After a description of molecular methods of diagnosing STIs, some notes on point-of-care test (POCT) will be useful, as some of these are based on principles of molecular methods.

What are point-of-care tests? {#sec2-31}
-----------------------------

Tests that offer immediate results, wherein patients can receive diagnosis and treatment in a single visit. These tests can be used at home or the site of service delivery, by trained or untrained users. They are easy to use, compact, durable and noninvasive with no stringent storage requirements. The turn-around-time to results is \<20 min, and both sensitivity and specificity are \>95%.

Need for point-of-care tests {#sec2-32}
----------------------------

World over, it is now being increasingly recognized that failure of health services is often due to unaffordability and inaccessibility of facilities (WHO-2004). Also, syndromic case management is not always a reliable method, especially for vaginal discharges.\[[@ref31]\]

The use of simple POCTs increases specificity of syndromic management reduces over-treatment and screens for asymptomatic STIs.

Characteristics of point-of-care tests {#sec2-33}
--------------------------------------

Any POCT, to be useful, should fulfill the A-S-S-U-R-E-D characteristics\[[@ref32]\]

A = Affordable

S = Sensitive

S = Specific

U = User friendly (easy-to-use, minimal training)

R = Robust (store at room temp.) and Rapid (result in \<20 min)

E = Equipment-free

D = Deliverable to end-users.

In addition, the test kit should have self-contained quality controls, and be amenable to safe waste disposal methods, at minimal cost. Thus, the treatment, counseling and partner notification of clients can be accomplished in the same visit.

Principles and types of point-of-care tests\[[@ref33]\] {#sec2-34}
-------------------------------------------------------

The POCTs currently available may be based on any of the following principles:

Agglutination/Precipitation Reactions, E.g., Rapid plasma regain.Immuno chromatography (ICT): (a) Lateral flow format. (b) Multiplex ICT. E.g., (HIV + Syphilis), (HIV + Syphilis + HBV/HCV), (Non treponemal + Treponemal tests). (c) Flow through format. E.g., Dot-blot tests. (d) Rapid test readers/scanners to remove observer bias, increase sensitivity and for quantitation.Emerging technologies: E.g., (a) Microfluidic assays - detect multiple analytes from single specimen (E.g., HIV and *T. pallidum*). (b) Rapid Molecular assays.

It is important to differentiate between Rapid tests and POCTs \[[Table 2](#T2){ref-type="table"}\] because the two are often used and understood to be synonymous.

###### 

Differences between Rapid test and POCT
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Syphilis {#sec2-35}
--------

The use of POCT in pregnant women and at-risk populations helps in reducing the disease burden in sexually active adults, very useful, especially in rural antenatal clinics.\[[@ref34]\] POCT for multiple STIs (E.g., HIV + Syphilis) and also for simultaneous detection of nontreponemal and treponemal antibodies for syphilis hold the promise of eliminating mother-to-child transmission of HIV and congenital syphilis.\[[@ref35]\]

Gonorrhea {#sec2-36}
---------

Many POCTs designed for gonorrhea have low sensitivity and specificity compared to NAAT. There is a growing need for POCT to test for resistance in gonococci. POCT based on isothermal amplification technologies for CT and NG is being developed.\[[@ref36]\]

HIV {#sec2-37}
---

The Ora-Quick HIV test is an FDA approved POCT that detects both HIV-1 and 2 in 20 min, (specificity - 99.98% and sensitivity - 93%). A POCT based on NAAT is being developed for pediatric setting. A simplified technology for CD4 count testing and viral load assay is also in the offing.\[[@ref36]\]

Point-of-care tests for other sexually transmitted infections {#sec2-38}
-------------------------------------------------------------

A self-testing POCT kit for *Trichomonas vaginalis* is available and can be easily used with training. A POCT for Bacterial vaginosis, which detects the sialase activity in vaginal fluid, although shown to have excellent sensitivity (88%) and specificity (95%) in comparison to Gram-stain, has no substantial evidence on its linkage to care.\[[@ref30][@ref36]\]

Point-of-care tests in the pipeline {#sec2-39}
-----------------------------------

A multi-assay, battery-operated device may soon become available with fully-automated test-specific cartridges, bar-codes, built-in internal controls, an analyzer, and bar-code.\[[@ref37]\]

Another novel technology, a microwave accelerated, metal-enhanced fluorescence test (MAMEF), is a microwave based cell lysis and DNA fragmentation, followed by DNA detection.\[[@ref38]\]

There are still some challenges to be addressed in POCTs, such as, quality assurance methods, linkage to patient care, and applications for partner services and surveillance.

CONCLUSION {#sec1-5}
==========

With the increasing availability of newer diagnostic technologies, we are on the verge of a major change in the approach to STI control. When diagnostic methods are faster and results more accurate, they are bound to improve patient care. As automation and standardization increase and human error decreases, more laboratories will adopt molecular testing methods. An effective STI control strategy is based on an accessible and well-trained healthcare workforce, suitable infrastructure, partner notification, disease surveillance, health promotion and outbreak investigation. For this, primary care physicians will continue to play a crucial role in ensuring the success of this important program.
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